Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. September 2025 07:15 ET | Quelle: Arch Biopartners

Arch Strengthens its Position as a Leading Kidney Therapeutics Company with the Acquisition of a Breakthrough Platform to Develop New Drugs Targeting Chronic Kidney Disease (CKD)

Arch acquires a new CKD platform that has the potential to produce next-generation CKD drugs for the pharmaceutical industry Based on a novel mechanism of action involving IL-32 and directly...
12. September 2025 08:00 ET | Quelle: Cocrystal Pharma, Inc.

Cocrystal Pharma Showcases CDI-988, the First Oral Antiviral in Development for Norovirus Infection, in a Podium Presentation at the International Calicivirus Conference

BOTHELL, Wash., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that President and co-CEO Sam Lee, PhD discussed the scientific foundation and clinical progress...
11. September 2025 08:00 ET | Quelle: Smith & Nephew UK Ltd

Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant...
10. September 2025 16:54 ET | Quelle: Vaxart, Inc.

Vaxart Reports Additional Phase 1 Data Supporting the Potential Efficacy of its Second-Generation Norovirus Oral Pill Vaccine Candidate

- Second-generation constructs induce robust increases in fecal IgA, which was shown to be correlated with protection against infection in the company’s previous Phase 2b challenge study - SOUTH SAN...
14. August 2025 17:00 ET | Quelle: Hesai Group

Hesai Group Reports Second Quarter 2025 Unaudited Financial Results

Quarterly net revenues were RMB706.4 million (US$98.6 million)1Quarterly lidar shipments were 352,095 unitsQuarterly net income was RMB44.1 million (US$6.2 million) SHANGHAI, China, Aug. 14,...
14. August 2025 08:15 ET | Quelle: Nuwellis, Inc.

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today...
12. August 2025 16:05 ET | Quelle: Lyell Immunopharma, Inc

Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025

Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphomaInitiated the...
08. August 2025 07:45 ET | Quelle: Boralex Inc.

Boralex annonce un résultat d'exploitation du deuxième trimestre comparable à celui de 2024 et poursuit activement ses activités de développement et de construction de projets

MONTRÉAL, 08 août 2025 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) annonce ses résultats pour le deuxième trimestre de l'exercice 2025. ...
08. August 2025 07:45 ET | Quelle: Boralex Inc.

Boralex reports second quarter operating income comparable to 2024 and actively pursue its development and construction activities

MONTREAL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (“Boralex” or the “Corporation”) (TSX: BLX) is pleased to report its results for the second quarter of 2025. HighlightsFinancial results ...
07. August 2025 11:22 ET | Quelle: Bitget Limited

₿itopia oleh Bitget Mengubah Degupan Jantung Menjadi Seni di UNTOLD Romania

CLUJ-NAPOCA, Romania, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bitget, peneraju global dalam pertukaran mata wang kripto dan syarikat Web3, memperkenalkan ₿itopia: #FeelThe₿eat, sebuah pemasangan...

Vorherige Seite

Nächste Seite